Who is sponsoring NCT04031001?

NCT04031001 is sponsored by Catharina Ziekenhuis Eindhoven.

What drugs are being tested in NCT04031001?

Interventions in NCT04031001: No-React Non-valved Conduit.

What condition does NCT04031001 study?

NCT04031001 studies Vascular Infections.

Is NCT04031001 still recruiting?

NCT04031001 is currently completed. Last updated 21 December 2023.

Last reviewed 2023-12-21 · How we verify

NCT04031001: VASC-REGAIN

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Vascular No-React Graft Against Infection

Completed Last updated 21 December 2023

What this trial tests

trial testing No-React Non-valved Conduit in Vascular Infections in 43 participants. Completed in 13 July 2021.

Timeline

22 December 2017

Primary endpoint
6 February 2021

13 July 2021

Quick facts

Lead sponsor	Catharina Ziekenhuis Eindhoven
Status	Completed
Study type	OBSERVATIONAL
Enrollment	43
Start date	22 December 2017
Primary completion	6 February 2021
Estimated completion	13 July 2021
Sites	1 location across Netherlands

Drugs / interventions tested

No-React Non-valved Conduit

Conditions studied

Vascular Infections — all drugs for Vascular Infections →

Sponsor

Catharina Ziekenhuis Eindhoven — full company profile →

Who can join

Eligibility, any sex, with Vascular Infections. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study seeks to demonstrate the effectiveness and safety of the Non-valved Conduit for CE marking on the basis of infection. The rationale for infection resistance with the conduit is that BioIntegral Surgical No-React® treated products have a well-documented history of infection resistance in hybrid vascular settings.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Catharina Ziekenhuis Eindhoven trials

Trials by the same sponsor.

NCT07314138 — Multivessel Minimally Invasive Coronary Bypass Grafting as HYBRID Revascularization Versus Conventional Off-pump Coronar · NA · not yet recruiting
NCT06768060 — Mindfulness-based Intervention Prior to External Cephalic Version · NA · recruiting
NCT06574867 — Evaluation of the viQtor Monitoring Solution on Surgical Wards · recruiting
NCT06374836 — The Contractile Response of the Thoracic Aorta to Vasoactive Substances · completed
NCT06401291 — Transcutaneous Electrical Nerve Stimulation in Patients With Angina and Non-Obstructive Coronary Arteries · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04031001 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Catharina Ziekenhuis Eindhoven
Last refreshed: 21 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04031001.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing